<code id='3F53D348D3'></code><style id='3F53D348D3'></style>
    • <acronym id='3F53D348D3'></acronym>
      <center id='3F53D348D3'><center id='3F53D348D3'><tfoot id='3F53D348D3'></tfoot></center><abbr id='3F53D348D3'><dir id='3F53D348D3'><tfoot id='3F53D348D3'></tfoot><noframes id='3F53D348D3'>

    • <optgroup id='3F53D348D3'><strike id='3F53D348D3'><sup id='3F53D348D3'></sup></strike><code id='3F53D348D3'></code></optgroup>
        1. <b id='3F53D348D3'><label id='3F53D348D3'><select id='3F53D348D3'><dt id='3F53D348D3'><span id='3F53D348D3'></span></dt></select></label></b><u id='3F53D348D3'></u>
          <i id='3F53D348D3'><strike id='3F53D348D3'><tt id='3F53D348D3'><pre id='3F53D348D3'></pre></tt></strike></i>

          leisure time

          leisure time

          author:explore    Page View:5
          PORTRAIT of Michelle Monje smiling with trees in the background. -- health coverage from STAT.
          New research led by Stanford neuro-oncologist Michelle Monje shines light on the electrochemical signaling pathway between neurons and cancer cells. Courtesy MacArthur Foundation

          The idea that cancer can hijack brain plasticity — subverting supple connections in the healthy brain that ordinarily lead to learning and memory formation — is gaining traction.

          First reported in Cell in 2015, research led by Stanford neuro-oncologist Michelle Monje showed that active nerve cells could promote the growth of high-grade gliomas, a form of brain cancer with a poor prognosis. Four years later, her lab revealed in a Nature paper that synapses between these neurons and gliomas spurred tumor growth, and last year, the team demonstrated how these same synapses revved up glioblastoma’s spread.

          advertisement

          There are still many questions about precisely how this process unfolds, and it’s too soon to say how solutions might be reached. But in a new paper published in Nature on Wednesday, Monje’s team solves another part of the puzzle, shining light on the electrochemical signaling pathway between neurons and cancer cells.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Duchenne breakthrough therapy leaves behind pioneering families
          Duchenne breakthrough therapy leaves behind pioneering families

          DuchennemusculardystrophyDr.EdwinP.Ewing,Jr./CDCPatFurlongwassittinginherhomeofficeinMiddletown,Ohio

          read more
          Snackable artificial intelligence, expert AI, and the pharma industry
          Snackable artificial intelligence, expert AI, and the pharma industry

          AdobeWhileit’swidelyacceptedthatthepharmaindustryisinnovativeinR&D,itisalsotruethatitcanbeslowat

          read more
          Walensky prepares to leave CDC — and Congress — behind
          Walensky prepares to leave CDC — and Congress — behind

          OutgoingCDCDirectorRochelleWalenskyJIMWATSON/AFPviaGettyImagesRochelleWalensky,theoutgoingdirectorof

          read more

          Crinetics acromegaly drug succeeds in late

          AresearcherworkinginthelabatCrineticsPharmaceuticalsinSanDiego.CourtesyCrineticsSANDIEGO—CrineticsPh